European Archives - Page 1175 of 1220 - European Medical Journal

EMJ

Big Ben, Covent Garden, and the Thames: Lessons Learned from a Visit to London—Collaboration Improves Outcomes

This past week I have had the honour and pleasure of introducing my book Women and Cardiovascular Disease in London. During the book-signing event, I was…

EMJ

Gilead Announces SVR12 Rates from Phase 3 Study Evaluating Harvoni® for the Treatment of Chronic Hepatitis C in Patients Co-Infected with HIV

Seattle, February 26, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced results from a Phase 3 study, ION-4, evaluating the once-daily…

EMJ

Gilead Announces Phase 3 Results for Investigational Once-Daily Single Tablet HIV Regimen Containing Tenofovir Alafenamide (TAF)

Seattle, February 26, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced detailed 48week results from two Phase 3 studies (Studies 104 and 111)…

EMJ

Living with a Rare Cancer

Lugano, 25 February 2015 – Within the “umbrella” of rare diseases, rare cancer patients confront particular problems. Most rare diseases have an…

Editor’s Pick: State of the Art of Aortic Valve Implantation: Indications, Outcomes, and Controversies

During the last decade, transcatheter aortic valve implantation (TAVI) has become a revolution in the treatment of high-risk severe aortic stenosis (AS).

Cost-Effectiveness of a Novel Self-Apposing Stent in ST-Segment Elevation Myocardial Infarction (STEMI) in France

The objective was to calculate the cost-effectiveness profile of STENTYS compared to conventional bare and drug-eluting stents (DES).

Left Ventricular Cardiomyopathy in Mitral Valve Prolapse: Fact or Fiction?

In most patients with mitral valve prolapse (MVP) without severe mitral regurgitation (MR), left ventricular (LV) function is preserved.

Functional Mitral Regurgitation: If the Myocardium Is Guilty Do We Also Need to ‘Rehabilitate’ the Valve?

Mitral regurgitation (MR) is the most frequent valvulopathy in the general population with an incidence that grows with age and is associated with a poor…

Transcatheter Options for Treatment of Mitral Regurgitation

Transcatheter therapy for valvular heart disease (VHD) as an alternative for surgery, as the standard of care, has emerged rapidly over the last 10 years.

Circulating Haemoglobin Levels and the Risk of Atherosclerosis in Asian Indian Populations

Background: The global burden of coronary heart disease (CHD) is estimated to be the highest on the Indian subcontinent. The pathophysiology of this…